The FDA approved a monthly maintenance dosing of intravenous lecanemab (Leqembi) for early Alzheimer's disease, said ...

Researchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...

There isn’t much research supporting any one supplement in terms of its benefits for longevity—except for potentially vitamin ...

Advocates worry that as HHS secretary, Robert F. Kennedy Jr. could undermine years of work to unlink autism and vaccines and ...

Ozempic divorce is current shorthand for the relationship difficulty that follows weight loss from GLP-1 drugs. I talk to a weight loss psychologist about what clinical, cultural and mental health ...

Mefenamic acid, a common anti-inflammatory drug already approved for pain management, has been found to significantly reduce ...

An enzyme that helps clear damaged mitochondria can act as a molecular switch and potentially prevent neurons from dying.

Antimicrobials, vaccines, and anti-inflammatories are associated with a reduced risk for Alzheimer disease and dementia.

A multicenter collaboration has identified a potential new treatment for an aggressive sarcoma arising in the nerves. The ...

Funding Freeze Sets Off New Fight Over Trump’s Vision for His Government President Trump’s order freezing trillions of dollars in federal grants and loans seeks to eliminate all spending on ...